Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation.
Limited quarterly history available
EPS needs at least three reported quarters before a meaningful chart is shown.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
N/A
EARNINGS PER SHARE (EPS) AVG 3Y
N/A
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Avalyn Pharma Inc. Common Stock
Market Cap
$1.14B
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14B
Earnings Per Share (EPS)
-0.99
TTM Avg
-0.32
3Y Avg
-0.47
5Y Avg
-0.45
Market Cap
$1.14B
Earnings Per Share (EPS)
1.69
TTM Avg
2.70
3Y Avg
2.53
5Y Avg
1.91
Market Cap
$1.14B
Earnings Per Share (EPS)
0.04
TTM Avg
0.06
3Y Avg
0.01
5Y Avg
-0.18
Market Cap
$1.14B
Earnings Per Share (EPS)
N/A
TTM Avg
-9.21
3Y Avg
-17.43
5Y Avg
-24.99
Market Cap
$1.11B
Earnings Per Share (EPS)
-0.93
TTM Avg
-2.25
3Y Avg
-2.35
5Y Avg
-1.62
Market Cap
$1.11B
Earnings Per Share (EPS)
N/A
TTM Avg
-3.05
3Y Avg
-3.05
5Y Avg
-3.05
Market Cap
$1.11B
Earnings Per Share (EPS)
-3.15
TTM Avg
-3.22
3Y Avg
-3.17
5Y Avg
-2.78
Market Cap
$1.10B
Earnings Per Share (EPS)
0.08
TTM Avg
-1.62
3Y Avg
-0.53
5Y Avg
-0.05
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalyn Pharma Inc. Common Stock (AVLN) | $1.14B | N/A | N/A | N/A | N/A |
| Harrow Health, Inc. (HROW)vs › | $1.14B | -0.99 | -0.32 | -0.47 | -0.45 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 1.69 | 2.70 | 2.53 | 1.91 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.14B | 0.04 | 0.06 | 0.01 | -0.18 |
| Nektar Therapeutics (NKTR)vs › | $1.14B | N/A | -9.21 | -17.43 | -24.99 |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | -0.93 | -2.25 | -2.35 | -1.62 |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.11B | N/A | -3.05 | -3.05 | -3.05 |
| Replimune Group, Inc. (REPL)vs › | $1.11B | -3.15 | -3.22 | -3.17 | -2.78 |
| STAAR Surgical Company (STAA)vs › | $1.10B | 0.08 | -1.62 | -0.53 | -0.05 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.10B | -3.10 | -1.89 | -1.38 | -1.38 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$-3.28
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.04 |
